April 2023
NCI Technology Opportunity Webinar: Focal Transcranial Magnetic Stimulation (TMS) Using High-Density Theta Burst: Translation and Back-translation
Register to attend a free webinar hosted by the NCI Technology Transfer Center. Attendees will learn about a new method for administering Transcranial Magnetic Stimulation (TMS). This new method improves both the instrumentation used to deliver TMS treatment, and the treatment’s magnetic pulse pattern. When applied to an awake rat treatment model, it was shown to provide significant improvement over conventional TMS treatment methods. The webinar will discuss new instrumentation that overcomes voltage and current limitations seen in devices currently being…
Find out more »August 2023
NCI Technology Opportunities Webinar: GPC1 as a New Therapeutic Target in Pancreatic Cancer: Development of Antibodies and CAR-T
Updated Registration Link: https://cbiit.webex.com/weblink/register/rd3e62547e5223e106861c6ec6ff496a6 Register to attend a free NIH webinar. Attendees will learn about a new targeted immunotherapy pancreatic cancer treatment centered on the Glypican-1 (GPC1) cell surface heparan sulfate proteoglycan protein which is overexpressed in pancreatic cancer. The webinar will be presented by Dr. Mitchell Ho, Deputy Chief, NCI Laboratory of Molecular Biology. Webinar overview: The inventors will discuss the development of their novel Chimeric Antigen Receptors (CARs) specific for GPC1 that include short Immunoglobulin subclass 4 (IgG4)…
Find out more »December 2023
NIH Technology Opportunity Webinar: Nestorone
Register to attend a free NIH webinar. Attendees will learn about a first-of-its-kind male contraceptive hormonal gel, Nestorone®/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self-applied transdermal gel is designed to provide full sperm suppression within 8-12 weeks and be reversible after 12-16 weeks of ending application. This presentation will showcase NES/T gel as an innovative, user-controlled option for male contraception.
Find out more »March 2024
NIH Technology Opportunity Webinar: An Adjuvanted Mucosal Subunit Vaccine for Preventing SARS-CoV-2 Transmission and Infection
Register to attend a free NIH webinar. Attendees will learn about a new adjuvanted subunit mucosal COVID-19 vaccine. Study results show this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection. This new technology combines an initial intramuscular injection with subsequent intranasal boost administration of a novel, molecular adjuvant nanoparticle formulation. The inventors will discuss this new intranasal vaccine formulation, the combined intramuscular prime and intranasal boost methodology, and results from…
Find out more »